Abstract
The Substance Abuse and Mental Health Services Administration (SAMHSA) is planning a rulemaking on extended take‐home criteria for methadone patients in opioid treatment programs (OTPs). SAMHSA, along with the Drug Enforcement Administration, regulates OTPs. And OTPs, in their turn, not only are in favor of the proposed changes, but have also advocated for them. ADAW learned about the plan earlier this month (see “SAMHSA chief medical officer on methadone THs and ODs,” ADAW Sept. 12, https://onlinelibrary.wiley.com/doi/10.1002/adaw.33547).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
